Friday, July 30th, 2010

BUY Chelsea Therapeutics International, Ltd. (CHTP) – last $2.26. CHTP a development stage pharmaceutical company, focuses on the acquisition, development, and commercialization of pharmaceutical products for the treatment of various human diseases. It offers droxidopa, an orally active synthetic precursor of norepinephrine, which is in two double-blind pivotal Phase III trials for the treatment of [...]